Anticoagulant Reversal Drug Pulled From U.S. Market

By News Health
2 hours Ago

(MedPage Today) — Andexanet alfa (Andexxa) will officially be taken off the U.S. market this month as an emergency reversal medication for contemporary blood thinners.
“The Biologics License Application for Andexxa has been withdrawn for commercial…

Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/119001

Author :

Publish date : 2025-12-12 22:22:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Survival Is Possible With Resuscitation in Some Extremely Premature Infants

CDC Says Kids' COVID Shots Reduced Emergency Department Visits

Study Makes the Case for Replacing Annual Breast Cancer Screening

Myasthenia Gravis Gets a New Drug Approval

The King's Cancer Speech; Multiple Studies Retracted; Mass Sperm Donor Had TP53 Gene

Lowering FDA's Drug-Approval Standards Is a Lose-Lose